Table 4.

Therapeutic apheresis with immunosuppressive agents in recurrent post-transplant focal segmental glomerulosclerosis.

Therapeutic apheresis	Drugs	Subjects	Results	Author [Ref]
PE	–	25	PR (n = 11) or CR (n = 7)	Uffing A [128]
	+Cyclophosphamide	1	No remission
	+Rituximab	30	PR (n = 9) or CR (n = 5)
IAS	+Rituximab	12 Children	PR (n = 2) or CR (n = 8) Two maintained remission without IAS and eight became IAS dependent after 3 months.	Allard L [122]
	+Rituximab	7 Patients	PR (n = 6) or CR (n = 1) 12 months after IAS, allograft survival was 100%	Naciri Bennani H [129]
LDL-A	+Methylprednisolone	7 Children	PR (n = 3) or CR (n = 4)	Shah L [125]

PE: Plasma exchange; IAS: immunoadsorption; LDL-A: low-density lipoprotein apheresis; PR: partial remission; CR: complete remission.